Cargando…
AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
Reactivation of the androgen receptor (AR) during androgen depletion therapy (ADT) underlies castration-resistant prostate cancer (CRPCa). Alternative splicing of the AR gene and synthesis of constitutively-active COOH-terminally truncated AR variants lacking the AR ligand binding domain has emerged...
Autores principales: | Li, Yingming, Hwang, Tae Hyun, Oseth, LeAnn, Hauge, Adam, Vessella, Robert L., Schmechel, Stephen C., Hirsch, Betsy, Beckman, Kenneth B., Silverstein, Kevin A., Dehm, Scott M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337879/ https://www.ncbi.nlm.nih.gov/pubmed/22266865 http://dx.doi.org/10.1038/onc.2011.637 |
Ejemplares similares
-
RF27 | LBSUN342 Ar-targeted Linked-read Sequencing Reveals Complex Ar Structural Variants In Castration Resistant Prostate Cancer Models
por: Zivanovic, Andrej, et al.
Publicado: (2022) -
Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer
por: Zivanovic, Andrej, et al.
Publicado: (2023) -
Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023) -
Regulation of androgen receptor splice variant AR3 by PCGEM1
por: Zhang, Ziqiang, et al.
Publicado: (2016) -
A birth of bipartite exon by intragenic deletion
por: Nozu, Kandai, et al.
Publicado: (2017)